Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx (MDXG) EPS (Basic) (2016 - 2025)

Mimedx (MDXG) has disclosed EPS (Basic) for 15 consecutive years, with $0.1 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) rose 100.0% to $0.1 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.33 through Dec 2025, up 17.86% year-over-year, with the annual reading at $0.33 for FY2025, 13.79% up from the prior year.
  • EPS (Basic) hit $0.1 in Q4 2025 for Mimedx, down from $0.11 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.31 in Q4 2023 to a low of -$0.11 in Q1 2022.
  • Historically, EPS (Basic) has averaged $0.03 across 5 years, with a median of $0.05 in 2024.
  • Biggest five-year swings in EPS (Basic): crashed 266.67% in 2022 and later soared 1650.0% in 2023.
  • Year by year, EPS (Basic) stood at -$0.01 in 2021, then crashed by 57.87% to -$0.02 in 2022, then skyrocketed by 1650.0% to $0.31 in 2023, then tumbled by 83.87% to $0.05 in 2024, then soared by 100.0% to $0.1 in 2025.
  • Business Quant data shows EPS (Basic) for MDXG at $0.1 in Q4 2025, $0.11 in Q3 2025, and $0.07 in Q2 2025.